Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: Central Nervous System Neoplasms trials
The registry lists 36 Central Nervous System Neoplasms studies with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor. 0 are open to participants now and 6 have results posted.
Early Phase 1 1Phase 1 19Phase 2 18No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With GliomaTerminatedNCT00631137Not applicableResults posted
- Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00486603Phase 1/2Results posted
- Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade GliomaCompletedNCT00404248Phase 1/2Results posted
- Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RTTerminatedNCT00068770Phase 2Results posted
- Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic GliomaCompletedNCT00058123Phase 2Results posted
- Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00052715Phase 2Results posted
- AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing SurgeryTerminatedNCT03965494Early Phase 1
- Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent GliomaCompletedNCT01480050Phase 1
- Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial AstrocytomaCompletedNCT00999622
- Studying Fentanyl in Patients With CancerTerminatedNCT00899951
- ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00770471Phase 1
- Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation TherapyTerminatedNCT00471653
- MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806WithdrawnNCT00433472Not applicable
- Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaCompletedNCT00401024Phase 1
- Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00390403Phase 1
- Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed GliomasCompletedNCT00253669
- Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00238277Phase 2
- Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed GliomasCompletedNCT00095771Phase 1
- Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary GliomaCompletedNCT00027625Phase 1
- Gefitinib in Treating Patients With Recurrent or Progressive CNS TumorsCompletedNCT00025675Phase 2
- CCI-779 in Treating Patients With Malignant GliomaCompletedNCT00022724Phase 1/2
- Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaCompletedNCT00010049Phase 1/2
- Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 1
- Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma MultiformeCompletedNCT00006452Phase 1
- Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorCompletedNCT00006358Phase 2
- Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma MultiformeCompletedNCT00006355Phase 1/2
- Fenretinide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006080Phase 2
- Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006025Phase 1
- Tipifarnib in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00005859Phase 1/2
- SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation TherapyCompletedNCT00004868Phase 1/2
- Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00004073Phase 2
- Gene Therapy in Treating Patients With Recurrent Malignant GliomasCompletedNCT00004041Phase 1
- Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With GlioblastomaCompletedNCT00003751Phase 2
- Irinotecan in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00003616Phase 1/2
- Temozolomide and Carmustine in Treating Patients With Anaplastic GliomaCompletedNCT00003176Phase 2
- O(6)-Benzylguanine in Treating Patients With Malignant GliomaCompletedNCT00002971Phase 1